NCT07151274 Impact of Ehlers-Danlos Syndrome on Gynaecological Health
| NCT ID | NCT07151274 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Rouen |
| Condition | Ehlers-Danlos Syndrome (EDS) |
| Study Type | OBSERVATIONAL |
| Enrollment | 156 participants |
| Start Date | 2025-07-07 |
| Primary Completion | 2026-07-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 156 participants in total. It began in 2025-07-07 with a primary completion date of 2026-07-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Dysmenorrhea is a common problem in gynaecology, significantly impacting patients' quality of life. Ehlers-Danlos syndrome (EDS) is associated with joint hypermobility, tissue fragility and chronic pain. Some studies suggest an increased prevalence of gynaecological disorders, including dysmenorrhea, in patients with EDS. However, data remain limited and few studies have compared the intensity and characteristics of dysmenorrhea in women with EDS. There is also little data on the prevalence of other gynaecological conditions in women with EDS. This study therefore aims to compare the severity of dysmenorrhea in patients with EDS and a control group in order to better characterise the gynaecological impact of EDS. It will also compare the prevalence of other gynaecological conditions between women with EDS and women without EDS.
Eligibility Criteria
Inclusion Criteria: * Women aged 18 or over. * Willing to participate voluntarily in the study via an online questionnaire. * Of childbearing age. * Reporting a diagnosis of EDS (all types) or not having EDS (control group) and being part of a database of healthy volunteers. Exclusion Criteria: * Minors (\< 18 years old). * Menopausal women * People who do not understand French well enough to complete the questionnaire. * Uncertain diagnosis of EDS (exclusion of participants who suspect EDS but without medical confirmation).
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07151274 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 50 Years, studying Ehlers-Danlos Syndrome (EDS). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07151274 currently recruiting?
Yes, NCT07151274 is actively recruiting participants. Contact the research team at melodie.lecointre@chu-rouen.fr for enrollment information.
Where is the NCT07151274 trial being conducted?
This trial is being conducted at Rouen, France.
Who is sponsoring the NCT07151274 clinical trial?
NCT07151274 is sponsored by University Hospital, Rouen. The trial plans to enroll 156 participants.